Canasa and Colitis ulcerative aggravated - a phase IV clinical study of FDA data
Summary:
Colitis ulcerative aggravated is reported as a side effect among people who take Canasa (mesalamine), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Humira, and have Depression.
The phase IV clinical study analyzes which people have Colitis ulcerative aggravated when taking Canasa. It is created by eHealthMe based on reports of 1,606 people who have side effects when taking Canasa from the FDA, and is updated regularly.
What is Canasa?
Canasa has active ingredients of mesalamine. It is often used in ulcerative colitis. eHealthMe is studying from 1,676 Canasa users. Check the latest studies of Canasa.
What is Colitis ulcerative aggravated?
Colitis ulcerative aggravated (inflammation of colon with ulcer) is found to be associated with 1,062 drugs and 325 conditions by eHealthMe. Check the latest studies of Colitis ulcerative aggravated.
1,606 people reported to have side effects when taking Canasa.
Among them, 139 people (8.66%) have Colitis ulcerative aggravated.
Among these 139 people:
How long have people been on Canasa when they have Colitis ulcerative aggravated? *
What is the gender of people who have Colitis ulcerative aggravated when taking Canasa? *
What is the age of people who have Colitis ulcerative aggravated when taking Canasa? *
What are other drugs people take besides Canasa? *
What are other side effects people have besides Colitis ulcerative aggravated? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Canasa and have Colitis ulcerative aggravated?
- Check whether Colitis ulcerative aggravated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Canasa:
- Canasa (1,676 reports)
Colitis ulcerative aggravated treatments and more:
- Colitis ulcerative aggravated (168 reports)
How severe was Colitis ulcerative aggravated and when was it recovered:
Expand to all the drugs that have ingredients of mesalamine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Canasa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Colitis ulcerative aggravated:
- Colitis ulcerative aggravated (1,062 drugs)
Browse all the conditions that are associated with Colitis ulcerative aggravated:
- Colitis ulcerative aggravated (325 conditions)
Related publications that referenced our studies
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
- Jacobsson H, Eriksen J, Karlén P, "Mesalazine-induced renal calculi", The American journal of case reports, 2015 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on mesalamine (the active ingredients of Canasa) and Canasa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cough and Acne - 6 seconds ago
- Could Proair Hfa cause Foreign Body Sensation In Eyes? - 8 seconds ago
- Could Tylenol W/ Codeine No. 3 cause Irritability? - 13 seconds ago
- Indapamide vs. Olmesartan Medoxomil, side effect and effectiveness comparison - 15 seconds ago
- Could Fentanyl Citrate cause Night Sweats? - 23 seconds ago
- Could Ibu cause Complement Factor C3 Decreased? - 43 seconds ago
- Could Acetylcysteine cause Night Sweats? - 58 seconds ago
- Carafate vs. Lidocaine, side effect and effectiveness comparison - a minute ago
- Drug interactions of Mirapex and Rocephin - a minute ago
- Could Trental cause Arrhythmias? - a minute ago